产品详情
文献和实验
相关推荐
注册证号 :培养基:EMEM(MEM+NEAA)+10%FBS+1%双抗
英文名 :BSC-1非洲绿猴肾细胞
库存 :现货库存
供应商 :南京万木春
肿瘤类型 :BSC-1非洲绿猴肾细胞/
细胞类型 :/
ATCC Number :收录:ATCCBSC-1非洲绿猴肾细胞
品系 :/
组织来源 :肾;自发永生
相关疾病 :/
物种来源 :非洲绿猴
免疫类型 :/
细胞形态 :/
是否是肿瘤细胞 :/
器官来源 :肾;自发永生
运输方式 :常温/干冰
年限 :三代内
生长状态 :贴壁
规格 :T25
BSC-1 非洲绿猴肾细胞
Catalogue No.: C272
Product Format: a T25 flask
Culture Properties:贴壁
Complete Growth Medium: 89%EMEM(MEM+NEAA)+10%FBS+1%双抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
Item | Specifications |
a T25 flask | 2X106 |
Manual | 1 copy |
(pembrolizumab) showed limited antitumor activity with an objective response rate (ORR) of 3.7% in 107 patients with advanced well-differentiated neuroendocrine tumors (NET) (6). The multicohort, phase 1 KEYNOTE-028 study in patients with PD-L1-positive NET treated with pembrolizumab demonstrated an ORR of 12.0% inpatients with carcinoid and 6.3% in patients with well-differentiated or moderately-differentiated pancreatic NET (7). In addition, based on a phase II basket trial of anti-CTLA-4 (ipilimumab) and anti-PD-1 (nivolumab)
南京万木春生物科技有限公司
实名认证
钻石会员
入驻年限:2年